By Tashi McQueenAFRO Staff [email protected] Type 2 diabetes mellitus (T2DM) is a chronic, life-altering condition affecting more than 35 million Americans. The disease occurs when a person’s ...
The prevalence of hearing loss among individuals with type 2 diabetes ranged from 40.6% to 71.9%, significantly higher than ...
Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes Daniel J. Drucker, MD, reviews the mechanisms of action of the DPP4 inhibitors. Diabetes Care, June 01, 2007 Vildagliptin: A ...
While uncontrolled diabetes is unfolding as a silent crisis in India, resulting in organ damage and failure, metabolic ...
Jessica Migala has been a health, fitness, and nutrition writer for almost 15 years. She has contributed to more than 40 print and digital publications, including Health and Runner's World. Jessica ...
When it comes to non-insulin medications that treat type 2 diabetes, there are a lot of options. Read on to learn more about these medications, as well as factors that play into which one is right for ...
Researchers have found in a new study published in Diabetes Research and Clinical Practice that prior psoriasis in patients ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising ...
Pilot Study Explores Dapagliflozin Use in Type 1 Diabetes Already approved for use in type 2 diabetes, the SGLT2 inhibitor dapagliflozin is tested in a pilot trial in patients with type 1 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback